PATENT CLAIM ANALYSIS

Application Number: 16025693
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "093210"]

Abstract:
This document provides methods and materials related to induced pluripotent stem cells. For example, induced pluripotent stem cells, compositions containing induced pluripotent stem cells, methods for obtaining induced pluripotent stem cells, and methods for using induced pluripotent stem cells are provided. In addition, methods and materials for using induced pluripotent stem cells to repair tissue (e.g., cardiovascular tissue) in vivo as well as methods and materials for using induced pluripotent stem cells to assess their therapeutic potential in appropriate animal models are provided.

Claim (Index 6):
The population of cardiomyocytes of  claim 1 , wherein said induced pluripotent stem cell comprising nucleic acid encoding said human Oct3/4 polypeptide, a human Sox2 polypeptide, and a human Klf4 polypeptide.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 95.0
- Lexical Diversity: 2.2381
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13058154', '14340161', '12656907', '12379564', '12213035']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7740102800087673
- 35 USC 102 Novelty (BERT): 0.6668060845538192
- Combined Prediction Score: 0.7632898604632725
- Mean Citation Score: 544.7912739999998
- Max Citation Score: 695.9251
- Similarity Product: 631.2353040676594

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test